Issued Patents All Time
Showing 26–50 of 52 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11339199 | Chimeric NK receptor and methods for treating cancer | Charles L. Sentman | 2022-05-24 |
| 11214616 | Anti-TIGIT antibodies and their use as therapeutics and diagnostics | Liu XUE, Qi Liu, Min Wei, Kang Li | 2022-01-04 |
| 11208454 | Chimeric NK receptor and methods for treating cancer | Charles L. Sentman | 2021-12-28 |
| 11202782 | Treatment cancers using a combination comprising PARP inhibitors | Lai-Xi Wang, Zhiyu Tang, Lusong Luo, Min Wei, Kang Li +4 more | 2021-12-21 |
| 11203637 | Anti-Tim-3 antibodies and use thereof | Liu XUE, Qi Liu, Hao Peng, Min Wei, Kang Li | 2021-12-21 |
| 11186637 | Anti-PD1 antibodies and their use as therapeutics and diagnostics | Kang Li, Jing Song, Lanlan Xu, Qi Liu, Hao Peng | 2021-11-30 |
| 11141496 | Use of berberine or derivative thereof in preparing myocardial perfusion imaging agent | Chengzhong Fan, Xiaoai Wu, Meng LIANG, Xiaoli Mei, Rang Wang +1 more | 2021-10-12 |
| 11034766 | Anti-B7-H6 antibody, fusion proteins, and methods of using the same | Charles L. Sentman | 2021-06-15 |
| 10940445 | Doping of inorganic minerals to hydrophobic membrane surface | Kaimin Shih, Xiao Li, Xiao-Mao Wang | 2021-03-09 |
| 10864203 | Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer | Jing Song, Lai-Xi Wang, Kang Li, Lusong Luo, Min Wei +3 more | 2020-12-15 |
| 10682378 | NKP30 receptor targeted therapeutics | Charles L. Sentman | 2020-06-16 |
| 10556952 | Heavy chain constant regions with reduced binding to Fc gamma receptors | Samuel Davis, Eric Smith, Supriya Patel | 2020-02-11 |
| 10544225 | Anti-PD-L1 antibodies and their use as therapeutics and diagnostics | Kang Li, Jing Song, Yucheng Li, Zhiying REN, Yanshen KANG | 2020-01-28 |
| 10519235 | Anti-PD1 antibodies and their use as therapeutics and diagnostics | Kang Li, Jing Song, Lanlan Xu, Qi Liu, Hao Peng | 2019-12-31 |
| 10336804 | Chimeric NK receptor and methods for treating cancer | Charles L. Sentman | 2019-07-02 |
| 10016730 | Doping of inorganic minerals to hydrophobic membrane surface | Kaimin Shih, Xiao Li, Xiao-Mao Wang | 2018-07-10 |
| 9988450 | Anti-PD1 antibodies and their use as therapeutics and diagnostics | Kang Li, Jing Song, Lanlan Xu, Qi Liu, Hao Peng | 2018-06-05 |
| 9834606 | Anti-PD1 antibodies and their use as therapeutics and diagnostics | Kang Li, Jing Song, Lanlan Xu, Qi Liu, Hao Peng | 2017-12-05 |
| 9833476 | NKP30 receptor targeted therapeutics | Charles L. Sentman | 2017-12-05 |
| 9790278 | Anti-B7-H6 antibody, fusion proteins, and methods of using the same | Charles L. Sentman | 2017-10-17 |
| 9217034 | Anti-PD1 antibodies and their use as therapeutics and diagnostics | Kang Li, Jing Song, Lanlan Xu, Qi Liu, Hao Peng | 2015-12-22 |
| 9211506 | Doping of inorganic minerals to hydrophobic membrane surface | Kaimin Shih, Xiao Li, Xiao-Mao Wang | 2015-12-15 |
| 8735553 | Anti-PD1 antibodies and their use as therapeutics and diagnostics | Kang Li, Jing Song, Lanlan Xu, Qi Liu, Hao Peng | 2014-05-27 |
| 8252914 | Chimeric NK receptor and methods for treating cancer | Charles L. Sentman | 2012-08-28 |
| 7994298 | Chimeric NK receptor and methods for treating cancer | Charles L. Sentman | 2011-08-09 |